Benign Conditions

September 23, 2020

The Optilume drug-coated balloon catheter system has been approved for use in European patients with urethral strictures.

August 06, 2020

Julia Beth Finkelstein, MD, MPH, CPPS, and colleagues evaluated the safety and costs associated with telemedicine appointments for pediatric urologic patients.

August 03, 2020

The drug-coated balloon catheter system is being compared with a sham device in a double-blinded randomized trial.

July 30, 2020

Minimally invasive water vapor thermal therapy offers rapid improvements in LUTS, QoL, and flow rate that remain durable to 5 years in patients with lower urinary tract symptoms due to benign prostatic hyperplasia.

July 23, 2020

The study compared the 2 procedures over 24 months of follow-up.

July 22, 2020

Retreatment rates were low with both aquablation and transurethral resection of the prostate.

July 21, 2020

In this interview, Jeffrey Weiss, MD, also describes “most exciting area in nocturia research.”

July 14, 2020

Significant improvements in BPH-related lower urinary tract symptoms were observed with the system.

July 10, 2020

Steven A. Kaplan, MD, explains the updates in the AUA 2020 guideline on lower urinary tract symptoms secondary to benign prostatic hyperplasia.

July 10, 2020

In this interview with Urology Times® Editorial Consultant Gopal Badlani, MD, Weiss also stresses the importance of a 24-hour voiding diary.

July 06, 2020

The Soltive Laser System, which uses thulium fiber laser technology, has been shown to generate finer particulate and dusted stones in half the time as a standard holmium yttrium aluminium garnet laser.

June 30, 2020

Alan W. Shindel, MD, provides an expert summary and analysis of the 2020 AUA Guidelines for Disorders of Ejaculation.

June 30, 2020

The reduction in urinary urgency incontinence episodes observed was “quite significant,” an investigator said.

June 29, 2020

The novel oral penem anti-infective compound sulopenem showed stronger clinical activity than ciprofloxacin in patients with uncomplicated urinary tract infections with quinolone resistant pathogens, according to findings from the phase 3 SURE1 trial.

June 26, 2020

In this interview, Gopal H. Badlani speaks to Jeffrey P. Weiss, MD, regarding how Weiss defines nocturia and separating the symptom from overactive bladder.

June 25, 2020

The guidelines are an evidence-based clinical reference for the treatment of patients with lower urinary tract symptoms secondary to BPH.

June 23, 2020

Only 1.5% of patients undergo repeat surgical intervention for BPH recurrence.

June 22, 2020

Patient-reported outcomes showed a superior experience regarding post-procedure BPH symptoms with the UroLift prostatic urethral lift over Rezum tissue ablation with steam injection.

January 30, 2019

Minimally invasive surgical options took front and center in 2018 when the AUA published its revised guideline on the surgical management of male lower urinary tract symptoms secondary to BPH.

November 20, 2018

Procedure safest when performed in